The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1308
ISSUE1308
March 23, 2009
Focalin XR for ADHD
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Focalin XR for ADHD
March 23, 2009 (Issue: 1308)
Short-acting methylphenidate (MPH) is effective for treatment of attention-deficit/hyperactivity disorder (ADHD), but its 3-5 hour duration of action usually requires mid-day dosing in school, which children may find disruptive or stigmatizing.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.